Key result
Novel 3DE imaging yields higher evaluation scores than traditional 3D systems for visualizing cardiac lesions.
Why the study?
The clinical value and operational characteristics of emerging advanced 3D echocardiographic technologies TrueVue, TrueVue Light, and TrueVue Glass for diagnosing heart diseases were not well established.
Do novel 3DE technologies (TrueVue, TrueVue Light, TrueVue Glass) improve image evaluation scores compared to traditional 3DE systems in patients with suspected structural heart diseases?
Cross-Sectional (n=272)
Do novel 3DE technologies (TrueVue, TrueVue Light, TrueVue Glass) improve image evaluation scores compared to traditional 3DE systems in patients with suspected structural heart diseases?
Novel 3DE imaging technologies (TrueVue, TrueVue Light, and TrueVue Glass) provide significantly higher image evaluation scores than conventional 3DE systems for viewing various cardiac lesions.
Answers are grounded in this paper and cite their sources.
Novel 3DE tools may improve visualization ratings; leaves open impact on diagnostic accuracy or outcomes in structural heart disease.
PURPOSE: To explore the value and operational points of TrueVue, TrueVue Light, and TrueVue Glass, which are emerging, advanced three-dimensional echocardiographic (3DE) technologies, for the clinical diagnosis of heart diseases. METHODS: Echocardiography examinations were performed in 272 patients with suspected structural heart diseases. Two-dimensional (2D) and real-time 3DE methods, including traditional and new 3D imaging techniques were used. The Likert scale was used to compare the novel and traditional techniques. The operational capabilities, advantages, and limitations of the new techniques were assessed. RESULTS: Twenty-one (7.7%) patients had normal cardiac structure, 98 (36.0%) had congenital heart diseases, 70 (25.7%) had acquired valvular diseases, 43 (15.8%) had cardiomyopathy, and 40 (14.7%) had other cardiac structural abnormalities. TrueVue provided high-resolution, realistic 3D images. TrueVue Light provided a virtual light source to apply light and shade effects that could be set at different locations and depths. TrueVue Glass was used for highlighting the borders of the chambers, thin valves, and vessels. The evaluation scores (Likert scale) of the novel 3DE tools were higher than those of traditional 3DE systems (p < 0.0001). CONCLUSIONS: For viewing various cardiac lesions, novel 3DE imaging was preferred over conventional displays in all surveyed groups. The use of TrueVue, TrueVue Light, and TrueVue Glass 3DE provides effective reference information, increases the diagnostic accuracy and efficiency, and optimizes the workflow of doctors who diagnose and treat heart diseases.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2026) conducted a cross-sectional in Suspected structural heart diseases (n=272). Novel 3DE imaging (TrueVue, TrueVue Light, and TrueVue Glass) vs. Traditional 3DE systems was evaluated on Evaluation scores (Likert scale) (p=<0.0001). Novel 3DE imaging tools (TrueVue suite) received higher Likert evaluation scores compared to traditional 3D systems for viewing cardiac lesions.
Synapse has enriched 10 related papers. Consider them for comparative context: